Drug interactions
Dexmedetomidine + Tazemetostat
Severity: Minor
Dexmedetomidine and Tazemetostat: minor interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Tazemetostat is metabolized by CYP3A4, and dexmedetomidine has only weak CYP3A4 inhibitory activity in vitro. A clinically relevant rise in tazemetostat exposure is unlikely, particularly with short-term dexmedetomidine use.
What this interaction means in plain words
Dexmedetomidine and Tazemetostat have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.
Dexmedetomidine belongs to Central Nervous System; Tazemetostat belongs to Miscellaneous.
Why it happens
Possible weak CYP3A4 inhibition by dexmedetomidine, with little clinical evidence of effect.
What to do
No dose adjustment is generally required; monitor for tazemetostat adverse effects if prolonged dexmedetomidine infusion is used.
What to ask your pharmacist
- Is there anything I should notice while taking both?
- Do I need to tell my doctor at the next visit?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Dexmedetomidine and Tazemetostat, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Dexmedetomidine
Other interactions of Tazemetostat
Frequently asked questions
Can I take Dexmedetomidine with Tazemetostat?
MediHelp rates the interaction as minor. Dexmedetomidine and Tazemetostat have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Tazemetostat is metabolized by CYP3A4, and dexmedetomidine has only weak CYP3A4 inhibitory activity in vitro. A clinically relevant rise in tazemetostat exposure is unlikely, particularly with short-term dexmedetomidine use.
How serious is the interaction between Dexmedetomidine and Tazemetostat?
MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No dose adjustment is generally required; monitor for tazemetostat adverse effects if prolonged dexmedetomidine infusion is used.
What other medicines interact with Dexmedetomidine?
MediHelp also lists interactions of Dexmedetomidine with, for example, Buprenorphine long-acting, Calcium / magnesium / potassium / sodium oxybates, Dextromoramide. The full list is on the Dexmedetomidine page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
